Latest AI and machine learning research in brain cancer for healthcare professionals.
INTRODUCTION: Artificial intelligence (AI) in medical radiation science (MRS) is increasingly embedded in everyday clinical workflows. As AI systems assume more operational roles, questions arise not only about technical competence, but about professional judgement, ethical responsibility, and what it now means to be "ready for practice". This study benchmarks perceived AI preparedness among Austr...
BACKGROUND: Overscanning is a common issue in CT planning, leading to unnecessary radiation exposure. PURPOSE: To develop a deep learning model to segment anatomical structures in scout views to optimize scan ranges and reduce radiation. MATERIALS AND METHODS: In this single-center retrospective study, 1146 patients undergoing CT between 2022 and 2025 were included. The model was trained on segmen...
BACKGROUND: The inevitable progression of high-grade gliomas has prompted a need for data-backed identification of compromised tissue prior to detecti...
Glioblastoma multiforme (GBM) is an aggressive primary brain tumour that presents significant treatment challenges due to its complex pathology and he...
PURPOSE: Detection of radiation-induced temporal lobe injury (RTLI) at the earliest radiologically detectable stage is important for timely interventi...
BACKGROUND: Artificial intelligence (AI) is considered to be a leading technology in radiation medical physics, which has the potential for improving ...
Glioblastoma is a highly aggressive primary brain tumor with near-universal recurrence despite maximal safe resection followed by standard chemoradiat...
Emerging evidence highlights hypoxia-responsive long non-coding RNAs (lncRNAs) as potential modulators in tumor biology. In this study, we explored th...
Glioma is the most common primary brain tumor, with high-grade glioma (HGG) posing significant clinical challenges due to its poor survival outcomes. ...
BACKGROUND AND OBJECTIVES: Radiomics-based machine learning models are increasingly used for clinical decision-making, yet their reliability is often ...
BACKGROUND: Accurate grading and prognostic assessment of glioma requires integrating key molecular biomarkers, including IDH mutation status and the ...
BACKGROUND: The prognosis for patients with glioblastoma (GBM) remains extremely poor, a challenge largely attributable to the complex nature of its m...
Neuro-cancer crosstalk plays an important role in the development and progression of Glioblastoma (GBM), but its specific mechanisms remain incomplete...
Compact robotic systems offer new opportunities for spinal procedures outside the operating room, but their potential for small-scale interventions su...
BACKGROUND: Gliomas are increasingly understood as disorders of distributed brain networks rather than focal lesions confined within radiographic marg...
BACKGROUND AND PURPOSE: Accurate delineation of organs of interest (OOIs, also commonly referred to as organs at risk, OARs) is crucial for safe radio...
The purpose of this investigation is to assess the outcome of Oxytactic microorganism in chemical reactive flow of TiO2Â +Â GO/water based hybrid nanofl...
The century-old vision of a "magic bullet" in oncology is being realized through the paradigm of precision theranostics, which formally integrates tar...
Glioblastoma (GBM), the most aggressive primary brain tumor, develops within a tumor microenvironment (TME) dominated by tumor-associated macrophages ...
PURPOSE: Differentiating true progression (TP) from pseudoprogression (PsP) in glioma is challenging due to overlapping enhancement patterns on conven...